Invited Lectures

  • Franco Buonaguro (Institute of Cancer, Naples, Italy)
    Advances of vaccines against chronic viral infections and cancer
  • Behazine Combadiere (Centre d’Immunologie et des Maladies infectieuses, INSERM, Paris, France)
    Technologies to measure vaccine efficacy
  • Aidar Ishmukhametov (Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, and Joint-Stock Company «Microgen», Moscow, Russia)
    Inactivated polio vaccine based on Sabin strains
  • Andrei Kozlov (Biomedical Center, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia)
    Immunotherapy of cancer, focus on the new targets
  • Margaret Liu (ProTherImmune; University of California, San Francisco, USA; Karolinska Institutet, Stockholm, Sweden)
    Progress in naked RNA vaccination
  • Shan Lu (University of Massachusets Medical School, USA)
    Viral vaccines, facing the emerging threats
  • Guanghui Ma (National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China)
    Emulsion particulate strategy: hollow particles for biomedical applications
  • Joon Rhee (Combinatorial Tumor Immunotherapy, Medical Research Center; Department of Microbiology, Chonnam National University Medical School, Chonnam, South Korea)
    Modulation of bacterial dysbiosis by vaccination
  • Ed Rybicki (Biopharming Research Unit, Molecular & Cell Biology Department, University of Cape Town, South Africa)
    Plant-made vaccines and biologics and the One Health Initiative
  • Anna-Lise Williamson (Institute of Infectious Disease and Molecular Medicine and Division of Medical Virology, University of Cape Town)
    Poxviruses as vaccine vectors